Categories: Health

Natural Remedies Advances Sleep Health Research with Holixer During National Sleep Awareness Month

BANGALORE, India, March 10, 2026 (GLOBE NEWSWIRE) — During National Sleep Awareness Month in March, Natural Remedies is highlighting human clinical research on Holixer, a standardized holy basil extract, that applies modern sleep science to a botanical traditionally used in India for stress and sleep support.

National Sleep Awareness Month brings focus to the public health consequences of insufficient and poor-quality sleep, from diminished stress resilience to impaired cognitive performance. Emerging evidence suggests that sleep consistency and stability may be just as important as total sleep duration in determining how rested a person feels.

“Stress and sleep are tightly linked, yet often studied in isolation,” said Suresh Lakshmikanthan, Ph.D., chief business officer at Natural Remedies. “Our research looks at how traditional botanicals perform when evaluated with modern clinical and sleep science tools.”

Natural Remedies’ research portfolio on Holixer includes multiple randomized, double blind, placebo controlled human trials involving approximately 170 adults experiencing elevated stress. Across these studies, participants receiving Holixer demonstrated improvements in sleep efficiency, reductions in nighttime awakenings, and faster sleep onset, indicating more stable sleep patterns.

A central focus of this work has been sleep microarchitecture, an emerging area of sleep science that evaluates the structure and stability of sleep cycles rather than total sleep duration. Using overnight sleep monitoring, a clinical study currently under peer review found that participants taking Holixer showed higher CAP A1 activity, a marker of more stable non-REM sleep and fewer nighttime disruptions.

These changes in sleep microarchitecture were associated with better next-day cognitive performance and subjective recovery. Researchers increasingly recognize that fragmented non-REM sleep and altered CAP patterns can contribute to impaired memory consolidation, stress dysregulation, and long-term cognitive vulnerability.

Holixer has also been shown to reduce stress biomarkers, including cortisol by up to 66%, while improving perceived stress among study participants. These results reinforce a systems-based perspective on how sleep quality and stress regulation interact and suggest that botanicals may influence both physiological and cognitive outcomes.

“As the science around sleep continues to evolve, understanding how stress physiology influences sleep stability is becoming increasingly important,” said Lakshmikanthan. “Our research reflects a growing movement toward evaluating sleep quality through objective, clinically validated measures that capture how people recover and function the next day.”

While National Sleep Awareness Month in March elevates awareness around sleep health, the conversation continues into May’s Better Sleep Month, with greater emphasis on long-term sleep support. The clinical research behind Holixer™ contributes to this broader dialogue by examining sleep quality and stress regulation as closely linked aspects of overall health. To learn more visit Natural Remedies at: https://naturalremedieshumanhealth.com.

About Natural Remedies
With a history dating back to 1950, Natural Remedies is an internationally recognized botanical healthcare company focused on combining traditional herbal wisdom with modern science. The company develops clinically supported, high-quality botanical branded ingredients used in health and wellness products around the world. Its team of 45-plus scientists has published more than 230 research papers in peer-reviewed journals and contributed to global standards in herbal medicine. Natural Remedies is committed to safety, sustainability, and innovation across its entire supply chain and all ingredients are certified kosher and halal.

A video accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/a26839b1-328b-4cfc-aa1d-8b471a602cfc

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/b39d6f6c-2f5b-4c69-908e-fbc53fde645a



GlobeNews Wire

Recent Posts

Over 500 Leaders from Across More Than 50 Countries and Territories Attend 56th Annual World Trade Centers Association Global Business Forum in Philadelphia

Flagship WTCA event delivers high-impact sector insights and global business connections across industries NEW YORK,…

52 minutes ago

EquiLend Acquires Finadium, Expanding Presence in Securities Finance Research & Consulting

Finadium to continue operating independently as a subsidiary of EquiLendNEW YORK, May 12, 2026 /PRNewswire/…

52 minutes ago

MEXC Commits to $500M Guardian Fund Expansion, Acquires 1,000 BTC to Strengthen User Protection

VICTORIA, Seychelles, May 12, 2026 /PRNewswire/ -- MEXC, a pioneer in 0-fee digital asset trading,…

52 minutes ago

Maveric Systems announces strategic brand positioning focused on Engineering Trust in AI-First Banking

CHENNAI, India and DALLAS, May 12, 2026 /PRNewswire/ -- Maveric Systems, a banking-exclusive technology specialist,…

52 minutes ago

NYSE Content Update: Disney CEO Josh D’Amaro Rings Bell Ahead of Upfront Event

NYSE issues a pre-market daily advisory direct from the trading floor.NEW YORK, May 12, 2026…

3 hours ago

Halia Therapeutics to Present Final Phase 2 Ofirnoflast Data in Lower-Risk MDS at EHA2026 and Announces Appointment of Han Myint, MD, FACP, as Chief Medical Officer

European Hematology Association (EHA) oral presentation to report 67% hematological improvement, durable transfusion independence, and…

3 hours ago